These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 8387217

  • 1. Pituitary-adrenal axis response to arginine vasopressin in patients with major depression.
    Carroll BT, Meller WH, Kathol RG, Gehris TL, Carter JL, Samuelson SD, Pitts AF.
    Psychiatry Res; 1993 Feb; 46(2):119-26. PubMed ID: 8387217
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Stimulation of the pituitary-adrenal system with graded doses of CRH and low dose vasopressin infusion in depressed patients and healthy subjects: a pilot study.
    Gispen-de Wied CC, Kok FW, Koppeschaar HP, Wynne HJ, Westenberg HG, Thijssen JH, van Ree JM.
    Eur Neuropsychopharmacol; 1993 Dec; 3(4):533-41. PubMed ID: 8111227
    [Abstract] [Full Text] [Related]

  • 5. Pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration in normal women and men.
    Rubin RT, Sekula LK, O'Toole S, Rhodes ME, Czambel RK.
    Neuropsychopharmacology; 1999 May; 20(5):434-46. PubMed ID: 10192824
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ, Ellis MJ, Evans MJ, Donald RA.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, Vicennati V, Carcello A, Labate AM.
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
    Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, Pasquali R.
    J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
    [Abstract] [Full Text] [Related]

  • 13. Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycaemia in patients with major depression.
    Kathol RG, Jaeckle RS, Lopez JF, Meller WH.
    Br J Psychiatry; 1989 Oct; 155():468-78. PubMed ID: 2558771
    [Abstract] [Full Text] [Related]

  • 14. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E.
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [Abstract] [Full Text] [Related]

  • 15. Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers.
    Scott LV, Medbak S, Dinan TG.
    Biol Psychiatry; 1999 Jun 01; 45(11):1447-54. PubMed ID: 10356627
    [Abstract] [Full Text] [Related]

  • 16. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Jun 01; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pituitary and adrenal responses to ovine corticotropin releasing factor and vasopressin injected into young and adult guinea-pigs.
    Pradier P, Tournaire C, Dalle M.
    J Dev Physiol; 1990 Sep 01; 14(3):163-9. PubMed ID: 1966108
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec 01; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

  • 20. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
    Clin Endocrinol (Oxf); 1995 Sep 01; 43(3):283-90. PubMed ID: 7586596
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.